US Stock MarketDetailed Quotes

Enanta Pharmaceuticals (ENTA)

Watchlist
  • 13.310
  • -0.040-0.30%
Close Apr 24 16:00 ET
  • 13.310
  • 0.0000.00%
Post 16:10 ET
386.25MMarket Cap-4.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals (ENTA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
9.76%18.62M
-3.42%65.32M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
Operating revenue
9.76%18.62M
-3.42%65.32M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
Cost of revenue
Gross profit
Operating expense
-26.26%29.87M
-20.42%150.67M
-24.63%33.51M
-11.74%37.21M
-20.81%39.45M
-23.42%40.5M
-12.52%189.33M
-11.01%44.46M
-24.19%42.16M
-12.97%49.82M
Selling and administrative expenses
-29.87%9.01M
-24.06%43.93M
-29.09%9.7M
-25.47%10M
-20.00%11.39M
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
-General and administrative expense
-29.87%9.01M
-24.06%43.93M
-29.09%9.7M
-25.47%10M
-20.00%11.39M
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
Research and development costs
-24.58%20.86M
-18.81%106.74M
-22.64%23.81M
-5.33%27.21M
-21.13%28.07M
-23.96%27.66M
-19.60%131.48M
-14.90%30.78M
-33.14%28.74M
-18.14%35.59M
Operating profit
52.20%-11.25M
29.86%-85.35M
38.41%-18.39M
21.88%-18.89M
25.14%-24.53M
32.51%-23.54M
11.31%-121.69M
3.79%-29.85M
34.12%-24.19M
16.95%-32.77M
Net non-operating interest income expense
-178.97%-661K
-54.02%1.76M
-153.95%-321K
-41.08%667K
-53.61%578K
-2.33%837K
-38.35%3.83M
-60.67%595K
-39.43%1.13M
-32.17%1.25M
Non-operating interest income
-13.47%2.42M
-36.07%9.44M
-34.95%2.07M
-34.47%2.29M
-39.83%2.29M
-34.88%2.8M
30.02%14.77M
-31.90%3.18M
-9.80%3.49M
107.35%3.81M
Non-operating interest expense
57.14%3.08M
-29.79%7.68M
-7.52%2.39M
-31.30%1.62M
-33.13%1.71M
-42.98%1.96M
112.51%10.94M
-18.09%2.58M
17.93%2.36M
--2.56M
Other net income (expense)
-46.58%39K
73K
Gain on sale of security
----
-46.58%39K
----
----
----
----
--73K
----
----
----
Income before tax
47.53%-11.91M
29.07%-83.55M
36.04%-18.67M
20.94%-18.23M
24.02%-23.95M
33.27%-22.71M
10.08%-117.79M
1.12%-29.19M
33.84%-23.05M
16.20%-31.52M
Income tax
105.77%24K
4.76%-1.66M
108.82%32K
107.34%29K
-259.50%-1.31M
33.12%-416K
-161.79%-1.74M
74.26%-363K
-109.36%-395K
-925.00%-363K
Net income
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
Net income continuous Operations
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
Minority interest income
Net income attributable to the parent company
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
Basic earnings per share
60.00%-0.42
29.93%-3.84
36.03%-0.87
20.56%-0.85
27.89%-1.06
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
Diluted earnings per share
60.00%-0.42
29.93%-3.84
36.03%-0.87
20.56%-0.85
27.89%-1.06
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue 9.76%18.62M-3.42%65.32M3.55%15.13M1.91%18.31M-12.48%14.93M-5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M
Operating revenue 9.76%18.62M-3.42%65.32M3.55%15.13M1.91%18.31M-12.48%14.93M-5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M
Cost of revenue
Gross profit
Operating expense -26.26%29.87M-20.42%150.67M-24.63%33.51M-11.74%37.21M-20.81%39.45M-23.42%40.5M-12.52%189.33M-11.01%44.46M-24.19%42.16M-12.97%49.82M
Selling and administrative expenses -29.87%9.01M-24.06%43.93M-29.09%9.7M-25.47%10M-20.00%11.39M-22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M
-General and administrative expense -29.87%9.01M-24.06%43.93M-29.09%9.7M-25.47%10M-20.00%11.39M-22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M
Research and development costs -24.58%20.86M-18.81%106.74M-22.64%23.81M-5.33%27.21M-21.13%28.07M-23.96%27.66M-19.60%131.48M-14.90%30.78M-33.14%28.74M-18.14%35.59M
Operating profit 52.20%-11.25M29.86%-85.35M38.41%-18.39M21.88%-18.89M25.14%-24.53M32.51%-23.54M11.31%-121.69M3.79%-29.85M34.12%-24.19M16.95%-32.77M
Net non-operating interest income expense -178.97%-661K-54.02%1.76M-153.95%-321K-41.08%667K-53.61%578K-2.33%837K-38.35%3.83M-60.67%595K-39.43%1.13M-32.17%1.25M
Non-operating interest income -13.47%2.42M-36.07%9.44M-34.95%2.07M-34.47%2.29M-39.83%2.29M-34.88%2.8M30.02%14.77M-31.90%3.18M-9.80%3.49M107.35%3.81M
Non-operating interest expense 57.14%3.08M-29.79%7.68M-7.52%2.39M-31.30%1.62M-33.13%1.71M-42.98%1.96M112.51%10.94M-18.09%2.58M17.93%2.36M--2.56M
Other net income (expense) -46.58%39K73K
Gain on sale of security -----46.58%39K------------------73K------------
Income before tax 47.53%-11.91M29.07%-83.55M36.04%-18.67M20.94%-18.23M24.02%-23.95M33.27%-22.71M10.08%-117.79M1.12%-29.19M33.84%-23.05M16.20%-31.52M
Income tax 105.77%24K4.76%-1.66M108.82%32K107.34%29K-259.50%-1.31M33.12%-416K-161.79%-1.74M74.26%-363K-109.36%-395K-925.00%-363K
Net income 46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M
Net income continuous Operations 46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M
Minority interest income
Net income attributable to the parent company 46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M
Basic earnings per share 60.00%-0.4229.93%-3.8436.03%-0.8720.56%-0.8527.89%-1.0633.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47
Diluted earnings per share 60.00%-0.4229.93%-3.8436.03%-0.8720.56%-0.8527.89%-1.0633.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -